Pacific Biosciences Of California (PACB) EPS (Weighted Average and Diluted) (2014 - 2026)
Pacific Biosciences Of California's quarterly EPS (Weighted Average and Diluted) came in at -$0.03 in Q1 2026, up 97.92% year-on-year from -$0.02 in Q1 2025, and up 76.92% quarter-over-quarter from -$0.13 in Q4 2025.
Pacific Biosciences Of California has reported EPS (Weighted Average and Diluted) for 11 years, with the latest figure at -$0.03 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) rose 97.92% year-over-year to -$0.03; the trailing twelve-month figure through Mar 2026 stood at -$0.43 (up 84.31% YoY), and the FY2025 full-year result was -$1.82, down 14.47% from the prior year.
- EPS (Weighted Average and Diluted) for Q1 2026 stood at -$0.03, up from -$0.13 in the prior quarter.
- The five-year high for EPS (Weighted Average and Diluted) was -$0.03 in Q1 2026, with the low at -$1.44 in Q1 2025.
- Average EPS (Weighted Average and Diluted) over 5 years is -$0.36, with a median of -$0.31 recorded in 2023.
- Year-over-year, EPS (Weighted Average and Diluted) tumbled 396.55% in 2025 and jumped 97.92% in 2026.
- Tracing PACB's EPS (Weighted Average and Diluted) over 5 years: stood at -$0.37 in 2022, then increased by 16.22% to -$0.31 in 2023, then sank by 41.94% to -$0.44 in 2024, then surged by 70.45% to -$0.13 in 2025, then surged by 76.92% to -$0.03 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.03 (Q1 2026), -$0.13 (Q4 2025), and -$0.13 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.61 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 1.93 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.89 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.66 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.51 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.85 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 2.24 |
| 10 | Pacific Biosciences Of California | 481.66 Mn | 205.70 Mn | 12.84 Mn | -0.03 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.03 |
| Dec 31, 2025 | -0.13 |
| Sep 30, 2025 | -0.13 |
| Jun 30, 2025 | -0.14 |
| Mar 31, 2025 | -1.44 |
| Dec 31, 2024 | -0.44 |
| Sep 30, 2024 | -0.22 |
| Jun 30, 2024 | -0.64 |
| Mar 31, 2024 | -0.29 |
| Dec 31, 2023 | -0.31 |
| Sep 30, 2023 | -0.26 |
| Jun 30, 2023 | -0.28 |
| Mar 31, 2023 | -0.36 |
| Dec 31, 2022 | -0.37 |
| Sep 30, 2022 | -0.34 |
| Jun 30, 2022 | -0.32 |
| Mar 31, 2022 | -0.37 |
| Dec 31, 2021 | -0.33 |
| Jun 30, 2021 | -0.21 |
| Mar 31, 2021 | -0.45 |
| Dec 31, 2020 | 0.46 |
| Sep 30, 2020 | -0.14 |
| Jun 30, 2020 | -0.15 |
| Mar 31, 2020 | 0.01 |
| Mar 31, 2019 | -0.20 |
| Sep 30, 2016 | -0.19 |
| Dec 31, 2015 | -0.02 |
| Sep 30, 2015 | 0.02 |
| Jun 30, 2015 | -0.16 |
| Mar 31, 2015 | -0.27 |
| Sep 30, 2014 | -0.13 |